Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Yang Zhou, Ying Su, Rui Yan, Xuewen Tang, Xuan Deng, Yao Zhu, Xiaoping Xu & Hanqing He. (2023) Knowledge and awareness of viral hepatitis and influencing factors among the general population aged 15–69 years in Zhejiang Province, China. Human Vaccines & Immunotherapeutics 19:2.
Read now
Read now
Articles from other publishers (26)
Wanying Zheng, Hongyu Li, Xingguang Yang, Luyang Wang, Yukun Shi, Haifeng Shan, Lianping He, Junyan Liu, Haotian Chen, Guangcheng Wang, Yang Zhao & Chunlei Han. (2023) Trends and prediction in the incidence rate of hepatitis C in Shandong Province in China from 2004 to 2030. Preventive Medicine 177, pages 107749.
Crossref
Crossref
Lingling Zheng, Xiaoli Zhang, Yuxia Nian, Wenjuan Zhou, Dan Li & Yong Wu. (2023) Multi-disciplinary cooperation for the micro-elimination of hepatitis C in China: a hospital-based experience. BMC Gastroenterology 23:1.
Crossref
Crossref
Hari V. Kalluri, Rajneet K. Oberoi, Qian Chen, Qi Jiang, Armen Asatryan, Negar N. Alami, Chen Yu & Wei Liu. (2023) Pharmacokinetics, Tolerability, and Safety of Glecaprevir/Pibrentasvir Co‐formulated Bilayer Tablet Following Repeated Administration in Healthy Chinese Adults. Clinical Pharmacology in Drug Development.
Crossref
Crossref
Yuanyuan Jia, Xiu Zou, Wei Yue, Jin Liu, Ming Yue, Yang Liu, Li Liu, Peng Huang, Yue Feng & Xueshan Xia. (2023) The distribution of hepatitis C viral genotypes shifted among chronic hepatitis C patients in Yunnan, China, between 2008–2018. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Crossref
Qiao Tang, Zhiwei Chen, Hu Li, Li Zhang, Mingli Peng, Yi Zeng, Xiaoqing Liu, Zubi Liu & Peng Hu. (2023) Molecular epidemiology of hepatitis C virus genotypes in different geographical regions of Chinese mainland and a phylogenetic analysis. Infectious Diseases of Poverty 12:1.
Crossref
Crossref
Ming Ren Toh, Evelyn Yi Ting Wong, Sunny Hei Wong, Alvin Wei Tian Ng, Lit-Hsin Loo, Pierce Kah-Hoe Chow & Joanne Ngeow. (2023) Global Epidemiology and Genetics of Hepatocellular Carcinoma. Gastroenterology 164:5, pages 766-782.
Crossref
Crossref
Zepei Feng, Peng Huang, Jinwei Zhang, Xueshan Xia, A‐mei Zhang, Tian Zeng, Qiong Chen, Chuanlong Zhu, Weilong Tan, Yun Zhang & Ming Yue. (2023)
KIR2DL4/HLA‐G
polymorphisms were associated with HCV infection susceptibility among Chinese high‐risk population
. Journal of Medical Virology 95:3.
Crossref
Crossref
Yanqi Lan, Ying Lu, Jinfeng Li, Shiqi Hu, Shuohua Chen, Yanhong Wang, Xiaojie Yuan, Hongmin Liu, Xiaomo Wang, Shouling Wu & Li Wang. (2022) Outcomes of subjects who are lean, overweight or obese with nonalcoholic fatty liver disease: A cohort study in China. Hepatology Communications 6:12, pages 3393-3405.
Crossref
Crossref
Eyal Klang, Shelly Soffer, Lee Alper, Orit Shimon, Yiftach Barash, Yana Davidov, Mariya Likhter, Oranit Cohen‐Ezra, Gil Ben Yakov & Ziv Ben‐Ari. (2022) Research trends analysis of chronic hepatitis C versus nonalcoholic fatty liver disease: A literature review text‐mining analysis of publications. Health Science Reports 5:6.
Crossref
Crossref
Gifty Marley, Wai‐Kay Seto, Weihui Yan, Polin Chan, Joseph D. Tucker, Weiming Tang & William C. W. Wong. (2022) What facilitates hepatitis B and hepatitis C testing and the role of stigma among primary care patients in China?. Journal of Viral Hepatitis 29:8, pages 637-645.
Crossref
Crossref
William C. W. Wong, Gifty Marley, Jingjing Li, Weihui Yan, Po-lin Chan, Joseph D. Tucker, Weiming Tang, Yuxin Ni, Dan Dan Cheng, Lou Cong & Wai-Kay Seto. (2022) A randomized controlled trial enhancing viral hepatitis testing in primary care via digital crowdsourced intervention. npj Digital Medicine 5:1.
Crossref
Crossref
Yuanyuan Song, Yuchang Li, Hanchao Cheng, Xinyu Du, Jiarun Mi, Linh-Vi Le, Zhongdan Chen, Polin Chan & Jing Sun. (2022) Eliminate Hepatitis C as a Public Health Threat: A Narrative Review of Strategies, Gaps, and Opportunities for China. Infectious Diseases and Therapy.
Crossref
Crossref
Liangying Gan, Dongyu Wang, Brian Bieber, Keith McCullough, Michel Jadoul, Ronald L. Pisoni, Fanfan Hou, Xinling Liang, Zhaohui Ni, Xiaonong Chen, Yuqing Chen & Li Zuo. (2022) Hepatitis C Prevalence, Incidence, and Treatment in Chinese Hemodialysis Patients: Results From the Dialysis Outcomes and Practice Patterns Study-China (2019–21). Frontiers in Medicine 9.
Crossref
Crossref
Zeyu Zhao, Meijie Chu, Yichao Guo, Shiting Yang, Guzainuer Abudurusuli, Roger Frutos & Tianmu Chen. (2022) Feasibility of Hepatitis C Elimination in China: From Epidemiology, Natural History, and Intervention Perspectives. Frontiers in Microbiology 13.
Crossref
Crossref
Yufen Tao, Xue Han, Nannan Liu, Lei Shi, Li Shi, Shuyuan Liu & Yufeng Yao. (2022)
Association study of
TAP
and
HLA‐I
gene combination with chronic hepatitis C virus infection in a Han population in China
. International Journal of Immunogenetics 49:3, pages 169-180.
Crossref
Crossref
Jicun Zhu, Peng Wang, Hua Ye, Jianxiang Shi, Xiao Wang, Keyan Wang, Fujiao Duan, Qian Yang, Guiying Sun & Jianying Zhang. (2022) Trend of the mortality of major liver diseases and its impact on life expectancy in China from 2006 to 2017. Journal of Public Health 44:1, pages 100-110.
Crossref
Crossref
Sheng Wu, Huangbo Yuan, Hong Fan, Yiyun Xu, Zhenqiu Liu, Xuefu Wu, Mingshan Wu, Xin Zhang, Tingting Shi & Tiejun Zhang. (2022) Evolutionary characteristics and immune mutation of hepatitis C virus genotype 1b among intravenous drug users in mainland, China. Journal of Viral Hepatitis 29:3, pages 209-217.
Crossref
Crossref
Xinyi Jiang, Le Chang, Ying Yan, Huimin Ji, Huizhen Sun, Fei Guo & Lunan Wang. (2021) A study based on four immunoassays: Hepatitis C virus antibody against different antigens may have unequal contributions to detection. Virology Journal 18:1.
Crossref
Crossref
Jing Sun, Hanchao Cheng, Muhammad Radzi Abu Hassan, Huan-Keat Chan & Jean-Michel Piedagnel. (2021) What China can learn from Malaysia to achieve the goal of “eliminate hepatitis C as a public health threat” by 2030 – a narrative review. The Lancet Regional Health - Western Pacific 16, pages 100261.
Crossref
Crossref
Xue MeiHongzhou Lu. (2021) Prevalence, diagnosis, and treatment of hepatitis C in Mainland China. Global Health & Medicine 3:5, pages 270-275.
Crossref
Crossref
Guolan Wu, Huili Zhou, Jing Wu, Duo Lv, Lihua Wu, You Zhai, Meihua Lin, Jingzi J. Wu & Jianzhong Shentu. (2021) Pharmacokinetics, Safety, and Tolerability of Ravidasvir, with and without Danoprevir/Ritonavir, in Healthy Subjects. Antimicrobial Agents and Chemotherapy 65:10.
Crossref
Crossref
Lin Liu, Lin Wang, Hua Zhang, Weidong Ou, Dan Li, Yi Feng, Hui Zhuang & Yiming Shao. (2021) Changing Epidemiology of Hepatitis B Virus and Hepatitis C Virus Coinfection in a Human Immunodeficiency Virus–Positive Population in China: Results From the Third and Fourth Nationwide Molecular Epidemiologic Surveys. Clinical Infectious Diseases 73:4, pages 642-649.
Crossref
Crossref
Tian-Shuo Zhao, Cunduo Jin, Yishan Wang & Fuqiang Cui. (2021) Knowledge, attitude and psychological status of patients living with hepatitis C in five provinces in China: a cross-sectional survey. BMJ Open 11:4, pages e040434.
Crossref
Crossref
William C. W. Wong, Nancy S. Yang, Jingjing Li, Hang Li, Eric Y. F. Wan, Thomas Fitzpatrick, Yuan Xiong, Wai-Kay Seto, Polin Chan, Ruihong Liu, Weiming Tang & Joseph D. Tucker. (2020) Crowdsourcing to promote hepatitis C testing and linkage-to-care in China: a randomized controlled trial protocol. BMC Public Health 20:1.
Crossref
Crossref
Hong Zhu, Hao Xing, Bin Yu, Wen-Tao Yan, Cheng-Wu Zhang, Ming-Cheng Guan, Ya-Hao Zhou, Hong Wang, Wan-Guang Zhang, Yao-Ming Zhang, Jie Li, Yu Wang, Ting-Hao Chen, Yong-Yi Zeng, Wan Yee Lau, Lei Liang, Chao Li & Tian Yang. (2020) Long-term survival and recurrence after curative resection for hepatocellular carcinoma in patients with chronic hepatitis C virus infection: a multicenter observational study from China. HPB 22:12, pages 1793-1802.
Crossref
Crossref
Xinyi Jiang, Xiaoting Lv, Le Chang, Ying Yan, Huimin Ji, Huizhen Sun, Fei Guo, Mary A. Rodgers, Peng Yin & Lunan Wang. (2020) Molecular characterization of hepatitis C virus for subtype determination and resistance-associated substitutions detection among Chinese voluntary blood donors. Antiviral Research 181, pages 104871.
Crossref
Crossref